Longradax (INN: Desflurane) is a liquid inhalation anesthetic composed of methyl ethyl ether halogenated with fluorine. It is used to induce and/or maintain anesthesia in adults, as well as in pediatric patients during surgical procedures.

Yevgeny Orachevsky, CEO of Pharmasyntez, emphasized that Longradax represents a significant advancement in improving anesthesia quality nationwide:

“Pharmasyntez Group's flagship plant in Irkutsk is pleased to introduce Longradax, an environmentally friendly anesthetic based on the active ingredient desflurane. This drug is critical in ensuring access to high-quality anesthesia for medical institutions throughout Russia. We are confident that Longradax will become an indispensable tool for surgeons and anesthesiologists, enabling safe and comfortable surgical procedures. Critically, in an era when access to modern medications is a top priority, our high-quality alternative to the original drug will lower anesthesia costs and increase patient access nationwide.”

Currently, Pharmasyntez is the sole supplier of this life-saving medication in the country.